Domača stranIX1 • FRA
add
IDEXX Laboratories Inc
Prejšnji trg. dan.
543,00 €
Dnevni razpon
555,40 € - 555,40 €
Letni razpon
325,20 € - 665,80 €
Tržna kapitalizacija
49,03 mrd. USD
Povprečni obseg
2,00
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
NASDAQ
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 1,09 mrd. | 14,28 % |
Stroški poslovanja | 333,51 mio. | 7,94 % |
Čisti dohodek | 248,19 mio. | 14,82 % |
Čista dobičkovnost prihodkov | 22,76 | 0,49 % |
Earnings per share | 3,08 | 17,56 % |
EBITDA | 363,33 mio. | 23,00 % |
Efektivna davčna stopnja | 19,15 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 180,07 mio. | −37,53 % |
Skupna sredstva | 3,35 mrd. | 1,74 % |
Skupne obveznosti | 1,75 mrd. | 2,78 % |
Celoten lastniški kapital | 1,61 mrd. | — |
Shares outstanding | 79,62 mio. | — |
Razmerje P/B | 26,96 | — |
Donosnost sredstev | 24,09 % | — |
Donosnost kapitala | 30,88 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 248,19 mio. | 14,82 % |
Denar iz dejavnosti | 355,76 mio. | 35,77 % |
Denar iz naložb | −28,13 mio. | 29,40 % |
Denar iz financiranja | −355,70 mio. | −52,80 % |
Neto sprememba denarnih sredstev | −28,10 mio. | −37,93 % |
Prost denarni tok | 286,03 mio. | 67,74 % |
Vizitka
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO. Wikipedia
Generalni direktor
Datum ustanovitve
19. dec. 1983
Sedež organizacije
Spletno mesto
Zaposleni
11.000
